Home » Drug Information » FDA-Approved Drugs » 1998
Medical Areas: Cardiology/Vascular Diseases | Endocrinology
View By: Year Company Therapeutic Areas Drug Names
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Astra Merck
Approval Status: Approved June 1998
Treatment Area: hypertension
Atacand has been approved for once-daily treatment of
hypertension. Atacand belongs to a group of antihypertensive
medications called angiotensin II receptor blockers (ARB) which
represent the first new class of antihypertensive agents in the
United States in more than a decade.
In clinical trials involving more than 7,000 hypertensive
patients, Atacand has been shown to reduce blood pressure over a
24-hour period.
Adverse experiences that occurred in at least one percent of
patients treated with Atacand and at a higher incidence vs. placebo
included back pain, dizziness, upper respiratory tract infection,
pharyngitis, and rhinitis. The drug should not be used in women who
are pregnant or by people who are allergic to any component of the
medication.
